CRISPR in the Retina: Evaluation of Future Potential

Area of Science:

• Ophthalmology
• Genetics
• Molecular Biology

Background:

• Inherited retinal degenerations cause irreversible vision loss due to limited retinal regeneration.
• Current gene therapies offer transient effects, highlighting the need for permanent solutions.
• The retina's accessibility and monitorable nature make it an ideal target for novel therapies.

Purpose of the Study:

• To explore the potential of CRISPR technology for correcting retinal degenerative diseases.
• To discuss strategies for implementing CRISPR-based genome surgery in ophthalmology.
• To identify the limitations and future prospects of CRISPR in treating inherited blindness.

Main Methods:

• CRISPR-Cas gene editing for targeted DNA modifications.
• In vivo and ex vivo therapeutic approaches for retinal diseases.
• Review of current genetic testing and its role in future CRISPR applications.

Main Results:

• CRISPR enables precise genome surgery for potential permanent correction of retinal defects.
• Both in vivo and ex vivo CRISPR applications are being explored for retinal gene therapy.
• The chapter provides a comprehensive overview of CRISPR's potential and challenges in ophthalmology.

Conclusions:

• CRISPR technology presents a promising avenue for permanent treatment of inherited retinal degenerations.
• Further research and development are crucial to overcome the limitations of CRISPR-based therapies.
• The retina is a viable target for in vivo genome surgery, offering hope for vision restoration.